GLP-1 use during early pregnancy may not increase risk of major adverse outcomes | Harvard T.H. Chan School of Public Health
hsph.harvard.edu
Taking GLP-1s during the first trimester of pregnancy does not appear to increase the risk of major adverse outcomes such as non-live birth, according to a new Harvard Chan School study.